Mayo Clinic Cancer Research Consortium

Rochester, Minnesota 55905

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Cardiac Toxicity, Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma

Studies at this site

• Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery — Completed
• Sunitinib in Treating Patients With Relapsed Multiple Myeloma — Completed
• Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer — Completed